|
and building factors in northern California office workers, June—September 1990
|
59
|
| 4—5 |
Types and locations of skin and mucous membrane symptoms in a Swedish questionnaire study |
62
|
| 4—6 |
Dose-response relationship of CCP handling frequency with symptoms reported by respondents |
64
|
| 4—7 |
Frequency of respiratory tract symptoms by type of paper and exposure level |
65
|
| 4—8 |
Positive findings from physician interviews of 53 respondents to a health questionnaire |
67
|
| 4—9 |
Dose-response relationship between CCP handling and mucous membrane and skin symptoms in two form-printing shops |
68
|
| 4—10 |
Incidence of symptoms in exposed workers and their matched comparison workers during two exposure periods |
69
|
| 4—11 |
Experimental laboratory investigations of allergic and irritative reactions in humans exposed to CCP |
72
|
| 4—12 |
Analysis of repeated insult patch test (RIPT) studies submitted by industry clients in response to 1987 and 1997 Federal Register notices on CCP and its components |
76
|
| 4—13 |
Frequency of occurrence and animal irritation category for chemicals identified in 12 French CCPs |
100
|
| 5—1 |
Summary of studies that examined exposure-response relationships between CCP handling and irritative symptoms of the skin, eyes, or upper respiratory tract |
108
|
| 5—2 |
Elevated ORs for CCP exposure and irritation of the skin, eyes, nose, or respiratory system reported in the indoor air cross-sectional studies |
109
|
